NO-Sensitive Hydrogel for Local Nitric Oxide Scavenging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing technologies fail to effectively capture and eliminate overproduced nitric oxide locally and selectively, leading to rapid diffusion and systemic toxicity, which complicates the treatment of inflammatory diseases like rheumatoid arthritis.

Innovation Solution

A nitric oxide-sensitive hydrogel is formed in-situ through a click chemical reaction using compounds represented by Formulae 1 to 3, which captures and eliminates overproduced nitric oxide, and releases a drug locally and selectively based on nitric oxide concentration, utilizing a crosslinking agent, micelle structure, and hyaluronic acid polymer for targeted treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If nanometer-scale technologies are used to capture nitric oxide, then ease of injection is improved, but rapid diffusion and removal to organs other than the injection site occurs causing systemic toxicity

Engineering Contradiction:
Improveease of injectionVSAvoidsystemic toxicity
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent creates a hydrogel with localized properties at the injection site that selectively captures nitric oxide. The hydrogel contains functional groups (such as diazeniumdiolates) that have high affinity for nitric oxide, creating a localized zone of nitric oxide scavenging that prevents systemic distribution while maintaining ease of injection

Inventive Principle:
Principle #3Local quality

2Quantity of substance

If nitric oxide is removed non-specifically, then nitric oxide levels are reduced, but numerous side effects occur including systemic toxicity

Engineering Contradiction:
Improvenitric oxide removalVSAvoidside effects
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The hydrogel acts as an intermediary substance that selectively interacts with nitric oxide through specific chemical functional groups. These groups (such as diazeniumdiolates) serve as mediators that bind nitric oxide with high selectivity, allowing removal of excess nitric oxide while preserving normal physiological levels and avoiding non-specific side effects

Inventive Principle:
Principle #24Intermediary (Mediator)

3Speed

If nitric oxide is captured rapidly, then nitric oxide levels are reduced quickly, but the duration of action is insufficient for chronic inflammatory diseases

Engineering Contradiction:
Improvenitric oxide capture speedVSAvoidduration of nitric oxide capture
Core Design Contradiction:
SpeedVSDuration of action of stationary object

Solution Approach 1:

The hydrogel provides continuous nitric oxide capture capability through its stable gel structure and persistent functional groups. The hydrogel matrix maintains a reservoir of nitric oxide-binding sites that continuously scaveng nitric oxide over extended periods, ensuring sustained therapeutic action for chronic inflammatory diseases rather than transient effects

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrogel effectively scavenges nitric oxide, reduces pro-inflammatory cytokines, and delivers therapeutic agents to the disease site, providing localized treatment with minimal invasiveness and avoiding systemic toxicity, thus alleviating inflammatory diseases.

Implementation Method 1

can effectively collect and scavenge nitric oxide overexpressed in the target site

Methodology Applied
Scientific EffectNitric oxide scavenging: Absorption (physical)

Implementation Method 2

a drug loaded in the hydrogel can be locally and sensitively released to a target site to be treated

Methodology Applied
Scientific EffectStimuli-responsive release:

Implementation Method 3

The hydrogel is formed through in-situ hybridization in a target site by means of a click chemical reaction

Methodology Applied
Scientific EffectClick chemical reaction: Chemical Bonding

Data Source

PatentUS12564598B2Nitric oxide-sensitive hydrogel
Publication Date: 2026.03.03 POSTECH ACADEMY INDUSTRY FOUNDATION
  • US12564598B2 patent drawing
  • US12564598B2 patent drawing
  • US12564598B2 patent drawing

AI summary

The present disclosure relates to a nitric oxide-sensitive hydrogel. The hydrogel is formed through in-situ hybridization in a target site by means of a click chemical reaction and is prepared using a nitric oxide-sensitive crosslinker. The hydrogel can effectively collect and scavenge nitric oxide overexpressed in the target site, and a drug loaded in the hydrogel can be locally and sensitively released to a target site to be treated. Therefore, the hydrogel can be effectively used to prevent and treat inflammatory disease caused by the overexpression of nitric oxide.